PTC Therapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
21.05.24
/
50%
€35.00
Target price
21.05.25
€29.48
Performance (%)
-7.43%
Price
19.06.24
€32.40
Summary
This prediction is currently active. With a performance of -7.43%, the SELL prediction for PTC Therapeutics Inc. by The_Goldman_Sachs_Gr is down slightly. This prediction currently runs until 21.05.25. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
PTC Therapeutics Inc. | -4.706% |
iShares Core DAX® | -0.315% |
iShares Nasdaq 100 | 1.250% |
iShares Nikkei 225® | -1.284% |
iShares S&P 500 | 1.141% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $32.00. They now have a "sell" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.60
28.05.24
28.05.24
€29.42
28.05.25
28.05.25
-7.14%
19.06.24
19.06.24
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€22.80
18.09.23
18.09.23
€20.61
18.09.24
18.09.24
36.84%
19.06.24
19.06.24